Target treatment with stereotactic radiation for recurrent gliomas | Zendy

Ayesha Ali | Zendy; Victor E. Chen | Zendy; Claire Zurlo | Zendy; James M. Taylor | Zendy; Christian Fernandez | Zendy; Wenyin Shi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Target treatment with stereotactic radiation for recurrent gliomas

Author(s) -

Ayesha Ali,

Victor E. Chen,

Claire Zurlo,

James M. Taylor,

Christian Fernandez,

Wenyin Shi

Publication year - 2020

Publication title -

chinese clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.733

H-Index - 22

eISSN - 2304-3873

pISSN - 2304-3865

DOI - 10.21037/cco.2020.03.05

Subject(s) - medicine , radiosurgery , medical physics , stereotactic radiation therapy , modalities , treatment modality , glioma , radiation therapy , stereotactic radiotherapy , radiation oncology , radiology , surgery , cancer research , social science , sociology

High grade gliomas (HGG) have a propensity to recur locally and have poor outcomes. As such, safe and effective treatment is paramount. Target treatment with stereotactic radiation allows safe re-irradiation through minimizing normal brain tissue radiation due to its high precision. In this review, we evaluated the clinical experiences using SRS and FSRT for re-irradiation in HGG. We report the radiobiological advantages and disadvantages of both modalities as well as the safety and efficacy published in current literature.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research